pentetic acid has been researched along with Osteosarcoma in 17 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To improve the accuracy of magnetic resonance imaging (MRI) in evaluating the response of osteosarcomas to preoperative chemotherapy, the authors developed a technique of mapping tumor necrosis and viability by quantitating slope values of gadolinium-DTPA (Gd-DTPA) uptake on dynamic fast low-angle shot (FLASH) images." | 7.68 | Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. ( Fairclough, DL; Fletcher, BD; Hanna, SL; Le, AH; Meyer, WH; Parham, DM, 1992) |
| "The ability of dynamic, gadolinium-enhanced magnetic resonance (MR) imaging to allow prediction of histologic responses to initial chemotherapy was evaluated in 20 patients with osteosarcoma (n = 12), Ewing sarcoma (n = 4), rhabdomyosarcoma (n = 3), or synovial sarcoma (n = 1)." | 3.68 | Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. ( Fairclough, DL; Fletcher, BD; Gronemeyer, SA; Hanna, SL, 1992) |
| "A new magnetic resonance (MR) technique, gadolinium-enhanced subtraction MR imaging, was developed to evaluate the response of patients with osteosarcoma to chemotherapy." | 3.68 | Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. ( Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D, 1992) |
| "To improve the accuracy of magnetic resonance imaging (MRI) in evaluating the response of osteosarcomas to preoperative chemotherapy, the authors developed a technique of mapping tumor necrosis and viability by quantitating slope values of gadolinium-DTPA (Gd-DTPA) uptake on dynamic fast low-angle shot (FLASH) images." | 3.68 | Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. ( Fairclough, DL; Fletcher, BD; Hanna, SL; Le, AH; Meyer, WH; Parham, DM, 1992) |
| "In nine patients with osteogenic or Ewing sarcoma, we evaluated the use of magnetic resonance angiography (MRA) to assess neovascularity non-invasively in vivo and to monitor response to chemotherapy." | 2.68 | Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography. ( Genant, HK; Gooding, CA; Johnston, JO; Lang, P; Matthay, KK; Rosenau, W; Vahlensieck, M, 1996) |
| "Nude mice bearing osteogenic sarcoma of human origin showed uptake in spiculated pattern." | 1.27 | The development and in-vivo behavior of tin containing radiopharmaceuticals--II. Autoradiographic and scintigraphic studies in normal animals and in animal models of bone disease. ( Atkins, HL; Brill, AB; Fairchild, RG; Meinken, GE; Oster, ZH; Richards, P; Sacker, DF; Som, P; Srivastava, SC; Tillman, DY, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Woude, HJ | 2 |
| Bloem, JL | 2 |
| Verstraete, KL | 1 |
| Taminiau, AH | 2 |
| Nooy, MA | 2 |
| Hogendoorn, PC | 2 |
| Holscher, HC | 1 |
| Hermans, J | 1 |
| Lang, P | 1 |
| Vahlensieck, M | 1 |
| Matthay, KK | 1 |
| Johnston, JO | 1 |
| Rosenau, W | 1 |
| Gooding, CA | 1 |
| Genant, HK | 1 |
| Sundaram, M | 1 |
| Volf, V | 1 |
| Luz, A | 1 |
| Schäffer, E | 1 |
| Müller, WA | 1 |
| Rencová, J | 1 |
| Ballou, JE | 1 |
| Dagle, GE | 1 |
| McDonald, KE | 1 |
| Buschbom, RL | 1 |
| Fletcher, BD | 2 |
| Hanna, SL | 2 |
| Fairclough, DL | 2 |
| Gronemeyer, SA | 1 |
| de Baere, T | 1 |
| Vanel, D | 1 |
| Shapeero, LG | 1 |
| Charpentier, A | 1 |
| Terrier, P | 1 |
| di Paola, M | 1 |
| Parham, DM | 1 |
| Meyer, WH | 1 |
| Le, AH | 1 |
| Seeger, LL | 1 |
| Widoff, BE | 1 |
| Bassett, LW | 1 |
| Rosen, G | 1 |
| Eckardt, JJ | 1 |
| Maas, R | 2 |
| Winkler, K | 1 |
| Delling, G | 1 |
| Heise, U | 1 |
| Triebel, HJ | 1 |
| Spielmann, RP | 1 |
| Härle, A | 1 |
| Reiser, M | 1 |
| Erlemann, R | 1 |
| Wuisman, P | 1 |
| Pettersson, H | 1 |
| Eliasson, J | 1 |
| Egund, N | 1 |
| Rööser, B | 1 |
| Willén, H | 1 |
| Rydholm, A | 1 |
| Berg, NO | 1 |
| Holtås, S | 1 |
| Oster, ZH | 1 |
| Som, P | 1 |
| Srivastava, SC | 1 |
| Fairchild, RG | 1 |
| Meinken, GE | 1 |
| Tillman, DY | 1 |
| Sacker, DF | 1 |
| Richards, P | 1 |
| Atkins, HL | 1 |
| Brill, AB | 1 |
| Bair, WJ | 1 |
| Thompson, RC | 1 |
| Bukhtoiarova, EM | 1 |
| Lemberg, VK | 1 |
| Erokhin, RA | 1 |
| Beliaev, IuA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomised Controlled Trial of the Effects of Fish Oil Emulsion in Total Parenteral Nutrition Upon Tumour Vascularity in Patients With Hepatic Colorectal Metastases[NCT00942292] | Phase 2 | 20 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pentetic acid and Osteosarcoma
| Article | Year |
|---|---|
Plutonium: biomedical research.
Topics: Aerosols; Animals; Autoradiography; Body Burden; Bone and Bones; Dogs; Dose-Response Relationship, R | 1974 |
2 trials available for pentetic acid and Osteosarcoma
| Article | Year |
|---|---|
Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Drug Combinations; | 1995 |
Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Double-Blind Method; Female; Gadolinium DTPA; Hum | 1996 |
14 other studies available for pentetic acid and Osteosarcoma
| Article | Year |
|---|---|
Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Edema; Fem | 1995 |
The use of gadolinium in the MR imaging of bone tumors.
Topics: Antineoplastic Agents; Bone Neoplasms; Contrast Media; Drug Combinations; Edema; Evaluation Studies | 1997 |
Effect of oral ZnDTPA on late effects of injected plutonium in rat.
Topics: Administration, Oral; Animals; Bone and Bones; Bone Neoplasms; Glomerulosclerosis, Focal Segmental; | 1999 |
Influence of inhaled Ca-DTPA on the long-term effects of inhaled Pu nitrate.
Topics: Aerosols; Animals; Body Weight; Bone Neoplasms; Calcium; Dose-Response Relationship, Drug; Dose-Resp | 1977 |
Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Contrast M | 1992 |
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined M | 1992 |
Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; | 1992 |
Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; Female; Femoral Neoplasms; Gadolinium DTPA; Hu | 1991 |
The potential of MRI in preoperative evaluation of chemotherapy-induced necrosis in osteosarcoma and Ewing's sarcoma.
Topics: Bone Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Necrosis; Organ | 1990 |
[Unusually localized osteosarcoma].
Topics: Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged | 1989 |
[The value of nuclear magnetic resonance tomography in staging of bone and soft tissue sarcomas].
Topics: Bone and Bones; Bone Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; | 1989 |
Gadolinium-DTPA enhancement of soft tissue tumors in magnetic resonance imaging--preliminary clinical experience in five patients.
Topics: Adult; Aged; Female; Fibrosarcoma; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; | 1988 |
The development and in-vivo behavior of tin containing radiopharmaceuticals--II. Autoradiographic and scintigraphic studies in normal animals and in animal models of bone disease.
Topics: Animals; Bone Diseases; Bone Neoplasms; Fractures, Bone; Humans; Kinetics; Mice; Mice, Nude; Neoplas | 1985 |
[Tumors in rats that have received pentacin after the administration of plutonium-239].
Topics: Animals; Bone Neoplasms; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Pentet | 1968 |